Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochimie

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0300-9084(96)82187-0PMID 8874799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide.

  1995cited by this paper
• SC-54684A: an orally active inhibitor of platelet aggregation.

  1995cited by this paper
• Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys.

  1995cited by this paper
• Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.

  1995cited by this paper
• Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

  1995cited by this paper
• Pharmacokinetics and pharmacodynamics of MK‐383, a selective non‐peptide platelet glycoprotein‐IIb/IIIa receptor antagonist, in healthy men

  1994cited by this paper
• Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.

  1994cited by this paper
• Epitopes and biological activities of two monoclonal antibodies to platelet integrin alpha IIb beta 3.

  1994cited by this paper
• Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time.

  1994cited by this paper
• Analysis of Human Platelet Glycoprotein llb-llla by Fluorescein Isothiocyanate-Conjugated Disintegrins with Flow Cytometry

  1994cited by this paper
• A humanized antibody specific for the platelet integrin gpIIb/IIIa.

  1994cited by this paper
• Ro 44-9883, a New Non-Peptidic GPIIb-GPIIIa Antagonist Prevents Platelet Loss in a Guinea Pig Model of Extracorporeal Circulation

  1993cited by this paper
• MK‐383 (L‐700,462), a Selective Nonpeptide Platelet Glycoprotein 1Ib/IIIa Antagonist, Is Active in Man

  1993cited by this paper
• Clinical Trials of Platelet Receptor Inhibitors

  1993cited by this paper
• Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparation.

  1993cited by this paper
• Regulation of vertebrate left–right asymmetries by extracellular matrix

  1992cited by this paper
• Epinephrine Augments von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation

  1992cited by this paper
• A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.

  1991cited by this paper
• Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca.

  1991cited by this paper
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

  1991cited by this paper
• Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri.

  1991cited by this paper
• Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.

  1991cited by this paper
• Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.

  1991cited by this paper
• Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms.

  1990cited by this paper
• Localization of von Willebrand Factor and Thrombin-Interactive Domains on Human Platelet Glycoprotein Ib

  1990cited by this paper
• Disintegrins: A Family of Integrin Inhibitory Proteins from Viper Venoms

  1990cited by this paper
• Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

  1989cited by this paper
• Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans.

  1989cited by this paper
• Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.

  1989cited by this paper
• Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.

  1988cited by this paper
• The platelet membrane glycoprotein IIb-IIIa complex.

  1988cited by this paper
• Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.

  1988cited by this paper
• Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactions.

  1987cited by this paper
• Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.

  1987cited by this paper
• New perspectives in cell adhesion: RGD and integrins.

  1987cited by this paper
• Integrins: a family of cell surface receptors.

  1987cited by this paper
• Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.

  1987cited by this paper
• Activation affects access to the platelet receptor for adhesive glycoproteins

  1986cited by this paper
• Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.

  1986cited by this paper
• A method for purifying the platelet membrane glycoprotein IIb-IIIa complex.

  1985cited by this paper
• Blood Flow Reductions in Stenosed Canine Coronary Arteries: Vasospasm or Platelet Aggregation?

  1982cited by this paper
• A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)

  1975cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• Snake venom disintegrins update: insights about new findings

  2023cites this paper
• Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications

  2021influential citation
• Snake Venom Disintegrins: An Overview of their Interaction with Integrins.

  2019cites this paper
• A Novel αIIbβ3 Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding

  2019cites this paper
• The venomics of Bothrops alternatus is a pool of acidic proteins with predominant hemorrhagic and coagulopathic activities.

  2010cites this paper
• Expression, purification and characterization of recombinant Jerdonitin, a P-II class snake venom metalloproteinase comprising metalloproteinase and disintegrin domains.

  2010cites this paper
• Synthetic and Natural Peptides as Antithrombotic Agents—A View on the Current Development

  2009cites this paper
• Comparative analysis of the venom proteomes of Vipera ammodytes ammodytes and Vipera ammodytes meridionalis.

  2008cites this paper
• MONOMERIC AND DIMERIC DISINTEGRINS: PLATELET ACTIVE AGENTS FROM VIPER VENOM

  2007influential citation
• Biological properties of a specific Gαq/11 inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress

  2006cites this paper
• Integrins in drug targeting-RGD templates in toxins.

  2006cites this paper
• A new protein structure of P-II class snake venom metalloproteinases: it comprises metalloproteinase and disintegrin domains.

  2003cites this paper
• Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.

  2002cites this paper
• Molecular cloning and sequence analysis of cDNA encoding flavoridin, a disintegrin from the venom of Trimeresurus flavoviridis.

  2002cites this paper
• tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor.

  2000cites this paper
• Lack of tPA Significantly Affects Antithrombotic Therapy by a GPIIb/IIIa Antagonist, but not by a Thrombin Inhibitor in Mice

  2000cites this paper
• Scientific and Standardization Committee Communications: Inventory Of Exogenous Inhibitors of Platelet Aggregation From Animal Sources On behalf of the Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

  2000cites this paper
• Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates

  1999cites this paper
• Nucleotide sequence of a cDNA encoding a common precursor of disintegrin flavostatin and hemorrhagic factor HR2a from the venom of Trimeresurus flavoviridis

  1999cites this paper
• Comparison of the antithrombotic effects and bleeding risk of fractionated aurin tricarboxylic acid and the GPIIb/IIIa antagonist GR144053 in a hamster model of stenosis.

  1999cites this paper
• Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.

  1998cites this paper
• Inhibitory Effect of GPIIb/IIIa Antagonists on Experimental Vascular Stenosis in Hamsters

  1998cites this paper
• レーザー光散乱を利用した凝集能の測定による薬効評価 (I): 血小板凝集への応用

  1998cites this paper
• Comparative Studies on the Antiplatelet Effects of a Humanized Anti-Platelet Glycoprotein IIb/IIIa Antibody (YM337) and ReoPro under Flow Conditions

  1998cites this paper
• Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis.

  1997cites this paper
• GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster

  1997cites this paper